ISG20: an enigmatic antiviral RNase targeting multiple viruses

FEBS Open Bio. 2022 Jun;12(6):1096-1111. doi: 10.1002/2211-5463.13382. Epub 2022 Feb 27.

Abstract

Interferon-stimulated gene 20 kDa protein (ISG20) is a relatively understudied antiviral protein capable of inhibiting a broad spectrum of viruses. ISG20 exhibits strong RNase properties, and it belongs to the large family of DEDD exonucleases, present in both prokaryotes and eukaryotes. ISG20 was initially characterized as having strong RNase activity in vitro, suggesting that its inhibitory effects are mediated via direct degradation of viral RNAs. This mechanism of action has since been further elucidated and additional antiviral activities of ISG20 highlighted, including direct degradation of deaminated viral DNA and translational inhibition of viral RNA and nonself RNAs. This review focuses on the current understanding of the main molecular mechanisms of viral inhibition by ISG20 and discusses the latest developments on the features that govern specificity or resistance to its action.

Keywords: ISG20; RNase; epitranscriptomic modifications; interferon; translational inhibition; virus inhibition.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Exoribonucleases / genetics
  • Interferons* / metabolism
  • RNA, Viral / genetics
  • Virus Replication / physiology
  • Viruses* / genetics
  • Viruses* / metabolism

Substances

  • Antiviral Agents
  • RNA, Viral
  • Interferons
  • Exoribonucleases